Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2015-11-19 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
Proxy form for use at the Extraordinary General Meeting to be held on Wednesday, 9 December 2015 at 10:30 a.m. (or at any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use at an Extraordinary General Meeting (EGM) of CSPC Pharmaceutical Group Limited. It includes instructions for shareholders to appoint proxies and vote on specific resolutions at the EGM. The content is procedural and related to voting arrangements rather than the meeting materials, voting results, or any financial or management reports. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the meeting.
2015-11-19 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for CSPC Pharmaceutical Group Limited. It includes details about the meeting date, location, agenda items such as approval of a whitewash waiver, adoption of a new share option scheme, and re-election of a director. The document is a formal announcement inviting shareholders to attend and vote at the meeting, with proxy instructions and board composition details. It does not contain financial statements, audit information, or detailed management discussion. It is not a report but a meeting notice and agenda. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2015-11-19 English
(1) APPLICATION FOR WHITEWASH WAIVER&#x3b; (2) PROPOSED ADOPTION OF THE NEW SHARE OPTION SCHEME&#x3b; (3) RE-ELECTION OF DIRECTOR&#x3b; AND (4) NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular sent to shareholders regarding an Extraordinary General Meeting (EGM). It contains proposals for a Whitewash Waiver, adoption of a new share option scheme, and re-election of a director. It includes a notice of the EGM, proxy forms, and letters from the board and independent financial advisors. This is a classic proxy solicitation document used to request shareholder votes for specific corporate actions.
2015-11-19 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from CSPC Pharmaceutical Group Limited stating the date of a board meeting to approve the unaudited third quarterly results for the nine months ended 30 September 2015. It does not contain the actual financial results or detailed financial data, but merely announces the upcoming board meeting where such results will be approved. The document length is only 1310 characters, which is quite short and fits the pattern of an announcement rather than a full report. Therefore, this is not an Interim/Quarterly Report (IR) itself, but an announcement related to the timing of financial results approval. Given the options, this fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2015-11-18 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding a further delay in the dispatch of a Circular related to a Whitewash Waiver, New Share Option Scheme, and Re-election. It references previous announcements and states that additional time is needed for the preparation of a valuation report to be included in the Circular. The document is short (3127 characters) and serves as an update on the timing of a shareholder communication rather than the communication itself or a detailed report. It does not contain financial statements, management discussion, or detailed report content. It is an announcement about the delay in sending a report (the Circular), not the report itself. Therefore, according to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA).
2015-11-16 English
DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding a delay in the despatch of a circular related to a Whitewash Waiver, New Share Option Scheme, and Re-election. It references a previous announcement and provides updated timing for the circular's distribution. The document is short (2953 characters) and serves as an informational update rather than containing substantive financial data or the circular itself. It does not contain financial statements, audit information, or detailed report content. The nature of the document is an announcement about the timing of a report (the circular), not the report itself. Therefore, according to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2015-11-12 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.